Want to see ASTH full AI Analyst Report?
ASTH Stock Chart & Stats
$18.59
$0.06(0.19%)
At close: 4:00 PM EST
$18.59
$0.06(0.19%)
Day’s Range― - ―
52-Week Range$18.08 - $51.60
Previous CloseN/A
Volume92.25K
Average Volume (3M)703.55K
Market Cap
$2.23B
Enterprise Value$1.57K
Total Cash (Recent Filing)$478.38M
Total Debt (Recent Filing)$1.07B
Price to Earnings (P/E)72.8
Beta1.05
Next Earnings
Aug 06, 2026EPS Estimate
0.34Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.62
Shares Outstanding49,583,420
10 Day Avg. Volume541,372
30 Day Avg. Volume703,552
Financial Highlights & Ratios
PEG Ratio-1.09
Price to Book (P/B)1.56
Price to Sales (P/S)0.38
P/FCF Ratio11.65
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$48.57Price Target Upside161.28% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9
EPS Forecast (FY)1.27
Revenue Forecast (FY)$4.00B
Bulls Say, Bears Say
Bulls Say
Free Cash Flow GenerationSustained, high free cash flow and strong year-over-year FCF growth provide durable financial flexibility to fund working capital in risk contracts, invest in platform capabilities, pay down debt and pursue tuck-in M&A. This cash generation reduces reliance on external financing and supports multi-quarter execution on deleveraging and investment plans.
AI-Enabled Platform & Operational LeverageA scalable AI-enabled operations layer materially lowers cost-to-serve while improving clinical metrics (gap closure, wellness visits). That combination creates durable provider stickiness, operating leverage as membership scales, and differentiated economics versus manual competitors—key for long-term margin recovery in value-based care.
Proven Value-Based Care PerformanceReplicated shared-savings success across multiple ACOs demonstrates operational capability to manage total cost of care and deliver payer-aligned outcomes. This track record builds credibility with payers and provider partners, underpins expansion in Medicare/ACO programs, and supports sustainable revenue from risk-bearing contracts as the industry moves toward value-based reimbursement.
Bears Say
Compressed ProfitabilityDespite scale, very low margins leave limited buffer for medical cost inflation or enrollment shocks and imply modest returns on equity. Sustained margin compression raises questions about long-term profitability resilience and whether platform efficiencies and synergies can restore durable margin profiles across expanded full-risk cohorts.
Enrollment & HQAF / Regulatory UncertaintyDependence on state Medicaid/Exchange enrollment trajectories and the uncertain timing/amount of HQAF payments makes revenue and margin forecasts sensitive to policy shifts. Regulatory changes to risk adjustment and MA rules or worse-than-expected exchange attrition could materially erode projected savings and upside, increasing execution risk over the medium term.
Working Capital Volatility From Full-Risk ConversionsTransitioning cohorts to full-risk creates pronounced receivable and liability swings that can compress near-term cash flows despite solid FCF trends. Additionally, newly converted full-risk cohorts typically start with lower margins and require maturation time, creating a window of earnings sensitivity and execution risk before full margin benefits are realized.
ASTH FAQ
What was Astrana Health Inc.’s price range in the past 12 months?
Astrana Health Inc. lowest stock price was $18.08 and its highest was $51.60 in the past 12 months.
What is Astrana Health Inc.’s market cap?
Astrana Health Inc.’s market cap is $2.23B.
When is Astrana Health Inc.’s upcoming earnings report date?
Astrana Health Inc.’s upcoming earnings report date is Aug 06, 2026 which is in 18 days.
How were Astrana Health Inc.’s earnings last quarter?
Astrana Health Inc. released its earnings results on May 07, 2026. The company reported $0.29 earnings per share for the quarter, missing the consensus estimate of $0.299 by -$0.009.
Is Astrana Health Inc. overvalued?
According to Wall Street analysts Astrana Health Inc.’s price is currently Undervalued.
Does Astrana Health Inc. pay dividends?
Astrana Health Inc. does not currently pay dividends.
What is Astrana Health Inc.’s EPS estimate?
Astrana Health Inc.’s EPS estimate is 0.34.
How many shares outstanding does Astrana Health Inc. have?
Astrana Health Inc. has 49,583,420 shares outstanding.
What happened to Astrana Health Inc.’s price movement after its last earnings report?
Astrana Health Inc. reported an EPS of $0.29 in its last earnings report, missing expectations of $0.299. Following the earnings report the stock price went up 8.925%.
Which hedge fund is a major shareholder of Astrana Health Inc.?
Currently, no hedge funds are holding shares in ASTH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Astrana Health Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$48.57 (161.28% Upside)
$48.57 (161.28% Upside)
Blogger Sentiment
Bullish
ASTH Sentiment 70%
Sector Average 66%
Sector Average 66%
Hedge Fund Trend
Increased
By 224.5K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 8.6%
Last 30 Days ▲ 24.3%
Last 30 Days ▲ 24.3%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
82.01%
12-Months-Change
Fundamentals
Return on Equity
3.88%
Trailing 12-Months
Asset Growth
77.19%
Trailing 12-Months
Company Description
Astrana Health Inc.
Astrana Health, Inc., which rebranded from Apollo Medical Holdings, Inc. in February 2024, is a healthcare management firm based in Alhambra, California, founded in 1985. This company delivers medical services throughout the United States, operating with a physician-centered approach powered by advanced technology. Its operations are structured across three distinct divisions: Care Partners, Care Delivery, and Care Enablement. Astrana Health utilizes its exclusive platform for population health management and healthcare delivery to implement an integrated, value-based care model. This strategic approach empowers the healthcare providers within its network to offer high-quality care to their patients. The organization provides extensive care coordination services to a broad spectrum of stakeholders, including patients, their families, primary care physicians, specialists, acute care hospitals, other inpatient facilities, physician groups, and health plans. Its robust physician network encompasses primary care doctors, specialized practitioners, advanced practice providers (extenders), and hospital-based physicians. Astrana Health serves a diverse patient base, primarily those with insurance coverage—such as private plans, Medicare, Medicaid, and HMOs—but also extends care to uninsured individuals.
ASTH Stock 12 Month Forecast
Average Price Target
$48.57
▲(161.28% Upside)
Technical Analysis
Healthcare Services
―
Pediatrix Medical Group
―
―
US Physical Therapy
―
Aveanna Healthcare Holdings
―
Ownership Overview
36.16% Insiders
16.58% Mutual Funds
0.52% Other Institutional Investors
22.14% Public Companies and
Individual Investors









